chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DEHYDRATED; URINARY INCONTINENCE; PLEURISY; CHEST PAIN; This spontaneous report received from a patient concerned a 65 year old male. The patient's height, and weight were not reported. The patient's past medical history included neck surgery, back surgery, left knee replacement, and covid-19 infection, and concurrent conditions included alcohol consumer, non smoker, and heart patient, and other pre-existing medical conditions included the patient has no known drug allergies and drug illicit use. the patient also had 29 surgeries. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1802068, and expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. Concomitant medications included alprazolam for drug used for unknown indication, apixaban, clopidogrel, lisinopril, metoprolol, ranolazine, rosuvastatin calcium, and . On 31-MAR-2021, the subject experienced pleurisy. On 31-MAR-2021, the subject experienced chest pain. On 01-APR-2021, the subject experienced urinary incontinence. On an unspecified date, the subject experienced dehydrated. Laboratory data (dates unspecified) included: Chest X-ray (NR: not provided) Pleurisy on left lung, and Diagnostic ultrasound (NR: not provided) No abnormal finding. The action taken with covid-19 vaccine  was not applicable. The patient recovered from pleurisy, chest pain on APR-2021, and urinary incontinence on 04-MAY-2021, and the outcome of dehydrated was not reported. This report was non-serious.
No additional AE/PQC reported; VAQTA administered after a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.   On 09-AUG-2021, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA) (lot # T023913; expiration date 31-MAR-2022; strength, dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The storage temperature was 9 Celsius degrees for 5 minutes. There was no previous temperature excursion. No additional adverse event or product quality complaint (PQC) was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T023913; expirationdate: 31-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Mother called today to say that school nurse noted that childs arm near injection site was swollen and red (golf ball sized). The mother said that the nurse also told her that the child had been scratching the area and the mother stated she wasn't sure if it wasn't a mosquito bite. I advised mother to take the child to the pediatrician to have it checked out.
mom reports that the evening of vax 5JAN93 pt had hr of screaming, rolled eyes, shaking, refused food x 20 & since has not been nl;now has some devel delays & verbal kinetic dyspraxia;
Right thigh with 2.5 inch oval rash, no warmth or tenderness.
Pain in L upper arm with 2 hours of vaccine did not radiate, stabbing, difficulty lift L arm up also  2 day hx of nausea, malaise
On 10/12/2001 redness, swelling and tenderness was noted at the injection site. The patient had a temperature of 100F. The fever lasted 1 day. On 10/18/2001 the patient's temperature was 101.5F and he developed a swollen lymph node in the groin. This temperature lasted 3 days. The patient was seen by the Dr on 10/19/2001 and was treated with Tylenol. On 10/20/2001 the patient's temperature was 101F, there was swelling of the lymph glands in the neck and groin, and the patient had a rash all over. On 10/21/2001 the rash was gone and on 10/22/2001 the patient was feeling better.
High fever 104 and Neutropenia. Pt presented with hyperpyrexia up to 104. Which began 24 hours after influenza vaccine. Noted to have decreased 1,700 5 days later.
Develop shingles? Herpes zoster on the Left arm that goes towards the back.
PT is a 81 y.o. female who presents with FACIAL DROOP AND LEFT ARM WEAKNESS. PATIENT'S HANDYMAN STATES THAT SHE STARTED WITH SLURRED SPEECH AT 11AM AND SYMPTOMS HAVE CONTINUED BUT SLIGHTLY IMPROVED. SHE IS NO LONGER WITH SLURRED SPEECH, BUT HAS PERSISTENT FACIAL DROOP AND LEFT ARM WEAKNESS.
Fever, Rash, ErythemaMultiform & UrticariaPruritus Narrative:
this is 1 of 2 pt from this site to devel an inj site rxn characterized by erythema, swelling, & discomfort p/vax;
Information has been received from a health professional concerning a 4 year old female patient who on 04/16/2001 was vaccinated with a dose of varicella virus vaccine live.  Subsequently, on approximately 04/16/2004, the patient developed breakthrough chickenpox with less than 50 lesions.  Follow up information indicated that there was not a single report of adverse reaction following varicella vaccination.  The reporter indicated that 49 other patients developed breakthrough cases of chickenpox.  No additional information is expected.
I experienced headache, nausea, diarrhea, fatigue, with first shot on 7/15/2021. After the second shot I experienced headache, nausea, diarrhea, fatigue, chest pain with fast beating, fluttering heartbeat and shortness of breath and developed acute diverticulitis without cause.  The chest pain got worse and was rushed by ambulance from urgent care to local Hospital and  referred to a cardiologist. After multiple EKG's, labs, Echocardiogram, and Holter monitor, the results show I  have significant PVCs (22.6%) Ventricular bigeminy, which did not begin until after the shot.
Joints started to hurt, overall fatigue.  Joint pain increased over next several days.  Weakness in legs as well on a few occasions.  Symptoms have continued this way until present (2.5 weeks later).
Information has been received through the Merck pregnancy registry from a registered nurse concerning a 22 year old female with no drug reactions/allergies, hypothyroidism, depression and a history of 3 pregnancies and 3 live birth who on 30-JAN-2007 was vaccinated with the first dose of Gardasil IM in right deltoid (Lot # 65519/1427F). Concomitant therapy included levothyroxine Na (SYNTHROID) and bupropion HCl (WELLBUTRIN). The patient was found to be pregnant (LMP 08-JAN-2007). The estimated delivery date was reported as 16-OCT-2007.  A pregnancy test, chlamydia culture, thyroid level and wellness screening panel were done (results not reported). An ultrasound done on 19-FEB-2007 for prenatal care and was noted to be normal. Additional information indicated that in April, 2007, week from LMP 12, the patient had an elective termination of pregnancy. It was unknown whether the fetus was normal and the products of conception examined. Additional information has been requested.
Left base of deltoid oblong circle 9cmX 6.5cm area of redness, sl swelling, warm.  no tenderness at this time. Onset 1/21/2021.  Today 1/22/21 slightly larger than yesterday - still denies pain.  Treated with ice pack TID and elevation of left arm.  Will continue to monitor
SWELLING OF INJECTION SITE TO THE SIZE OF APPROXIMATELY A LARGE WALNUT, AND TENDERNESS.  UNCLEAR ON HOW LONG LASTED.  ICE PACK APPLIED.
blood (thick) running from my nose; tongue had splits on it; sight became dark red, swollen and hard; hot flashes; face flushing; itchy neck; Ears ringing; bit wheezy; sight became dark red; sight became dark red, swollen; This is a spontaneous report from a contactable consumer (unspecified relationship with patient) reported for patient. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0164, and Expiration date: Unknown), intramuscular, administered in deltoid left on 05May2021 15:40 as dose 1, single for COVID-19 immunization, at hospital. Medical history included none. There were no concomitant medications. There was no prior vaccination. The patient initially had an itchy neck and a bit wheezy, hot flashes, face flushing. Took a Benadryl, ears ringing, on an unspecified date in 2021. Then after 3 days the sight became dark red, swollen and hard, continued for 1 week. Then on 11Jun2021, while sleeping the patient awoke to "blood (thick) running from my nose (about 2 ounces). The patient's "tongue had splits on it". The outcome of the event "sight became dark red, swollen" (swelling), "sight became dark red" (erythema) and "sight became dark red, swollen and hard" (skin hypertrophy) reported as resolved on an unspecified date in 2021. The investigation assessment was not provided. No relevant tests were performed. The outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
SORE FACE; SORE NECK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced sore face, and sore neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore face and sore neck was not reported. This report was non-serious. This case, involving the same patient is linked to 20220238109.
Nausea (not throwing up); Headache; Chills; malaise; Stuffy nose; Loss of appetite.
Started Tuesday with a quarter local reaction Wednesday mother was concerned and went to the ER, told to ice and given TYLENOL. Came to clinic requested BENADRYL cream, site increased to 9x8.
FLU SYMPTOMS; SORE ARM; This spontaneous report received from a patient concerned a 74 year old female of unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 07-APR-2021 for covid-19 prophylaxis. On an unspecified date, the patient experienced sore arm (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered at 11:00 or 12:00 on 14-JAN-2022 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 74 years old. No concomitant medications were reported.  On 14-JAN-2022 at 18:00, the patient started experiencing sore arm, chills, fever, headache, and muscle pain (muscle pain lasted 5 days) (dose number in series 2). The patient also started experiencing shaking, feeling freezing cold and patient couldn't get warm (dose number in series 2). Patient states she just wanted to go to bed but needed lots of blankets and warmed up by 02:00. When patient woke around 02:00 on 15-JAN-2022, she had fever of 102 (Body temperature) which lasted until probably 20:00 (dose number in series 2). The patient had highest fever for 12 hours mark after injection, and then symptoms started to subside. Patient states it was regular flu symptoms (dose number in series 2). Patient got hit with it and then all of a sudden it was over, patient links it to her COVID-19.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu symptoms, and sore arm on JAN-2022. This report was non-serious. This case, involving the same patient is linked to 20231055429.
Pt had a swollen arm, Tender to touch, Heavy feeling, No Fever. Mom gave pt IBU at night.
This spontaneous report as received from a healthcare worker (also reported as office administrator) refers to a 4 years old male patient with cerebral ventricular shunt, cleft palate, asthma and prophylaxis and a medical history of history of brain tumor and no drug reactions or allergies. On 09-JUN-2009, dose 1 M-M-R II (dose, route and lot # not reported) and on 15-NOV-2012, dose 2 M-M-R II (lot # H011907 exp: 03-JUL-2014) (dose and route not reported). Other suspect therapies included, on 09-JUN-2009, the patient was vaccinated subcutaneously with dose 1 VARIVAX (Merck) (dose and lot # not reported). On 15-NOV-2012, the patient was vaccinated subcutaneously with dose 2 VARIVAX (Merck) (lot # H013182 exp: 05-JUL-2014) (dose not reported), and on 15-NOV-2012 influenza virus vaccine (unspecified) (Manufacturer by Sanofi). No concomitant medications were reported. The office administrator stated that on 15-NOV-2012, a patient had an anaphylaxis reaction. The patient's mother and patient left the office and was in the parking lot when the patient's mother called to say the patient was not acting correct. The patient was brought back into the office and had multiple episodes of vomiting, broke out in urticaria, and experienced diminished breath sounds bilateral. The patient was sent to the emergency room by ambulance. The patient received VARIVAX (Merck), M-M-R II and influenza virus vaccine (unspecified) (Manufacturer by Sanofi) in the past with no problems. The patient ate eggs on the morning of 15-NOV-2012 with no problems. The patient was put on treatment with intramuscular EPIPEN; BENADRYL; nebulizer of albuterol and supplemental oxygen. The outcome of anaphylaxis reaction was reported as recovered/resolved on 15-NOV-2012. The relatedness for all adverse events was unknown for M-M-R II, influenza virus vaccine (unspecified) and VARIVAX (Merck). All events were considered to be disabling and life threatening and medically significant by the reporter. Additional information has been requested.
Immediately following vaccination, pt experienced itching in her whole arm. Within hours, a 4" diameter area at the injection site became red, hard, hot and itchy. Pt treated with hydrocortisone for itching. The on duty nurse described the area as induration with redness.
Ringing in  both ears,; fullness feeling in both ears; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 12:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to aspirin and sulfur. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and levothyroxine sodium (SYNTHROID) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20 Mar2021 at 15:45, the patient had experienced ringing and fullness feeling in both ears. Adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient had received any therapeutic measures for the reported events. The clinical outcome of the events ringing and fullness feeling in both ears was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
This case was reported by a pharmacist and described the occurrence of injection site pain in a 28 year old patient who received hepatitis B vaccine recombinant (Engerix-B).  The patient did not receive any concurrent medications.  On 01/23/2004, the patient received the third and final dose of the series of Engerix-B in the arm.  The expiration date for this administration of Engerix-B was on 12/04/2002.  At an unspecified time following administration of Engerix-B, on 01/23/2004, the patient experienced prolonged injection site pain.  The event resolved on 01/27/2004.  The reporter stated that the event could possibly have been related to erroneous administration, but noted that 2 additional parents had experienced similar events to be probably related to vaccination with Engerix-B.
Pfizer COVID-19 vaccine was administered to patient on 4/27/22. Vial was placed in refrigerator on 2/10/22 and NP entered expiration date 5/31/22 in system. 10 week expiration date was 4/21/22. Lot # FK9895; vial exp date 9/2021; NDC: 59267-1025-04.
Right after injection pain at the injection site, and inability to move right arm higher than patients waist. Starting at 1:20pm on the 20th a headache, nausea, and chills began. On Sunday morning at 8:00 patient woke with chest pain, coughing fits, and felt like an elephant was sitting on her chest. On Monday a rash and heat started around injection site at 11:00am. Patient is still experiencing shortness of breath, fatigue, and nausea. Prescribed inhaler and space chamber to help with shortness of breath.
Initial unsolicited report received from a physician on 03 September 2015. This case is linked to 2014SA030217. (same reporter). This case involves a [age and gender unknown] patient who was vaccinated with a [dose unknown] intramuscularly [dose in series unknown] dose of ADACEL (batch number U4825AA, expiry date was not reported) in the right deltoid on 03 March 2015. The patient medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient experienced abrasion of forearm. Lab data and corrective treatment was not reported. The outcome of event was not reported. List of documents held by sender: none.
Vaccine administered at approximatly 8:20.   8:25- Patient became tachycardic with heart rate at 140 bpm. She also felt like "her throat was closing". Shortness of breath also experienced. Blood pressure held steady at 144/84.  8:30- 50mg Benadryl administered. Pulse 124. BP 149/89.  8:35- Lorazepam 0.5 mg IV administered. Pulse 112. BP 138/80.  8:45- Patient felt chilled.  9:13- Pulse 93. Blood pressure: 122/70. EKG brought in. Patient's EKG appeared normal.  9:50- Patient visited by physician. Later sent home.
I started itching on my elbows and the blood flowed to my skin. My temperature dropped it happened in 5 different areas on my body. I knew it wasn't normal it caused me to be red, itchy and swollen. I was given an Epi-pen by my doctor.
PT complained of chest pain, chest tightness, dizziness, headache, and fever (100.4) approximately 19 hours after receiving the first dose of the Pfizer COVID-19 vaccine. As a result of her symptoms, she was seen by a cardiologist on 8/25 and diagnosed with Pericardial Effusion. PT was given 400 mg ibuprofen twice daily to treat symptoms.
she got up this morning her arm hurt; she had difficulty moving it; arm goes numb at injection site/it intermittently lost feeling; This is a spontaneous report from a contactable consumer (patient).  A 28-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 10Feb2021 (Batch/Lot Number: E18982) as single dose for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. The patient reported that she got her first covid vaccination yesterday (10Feb2021) and when she got up this morning (11Feb2021), her arm hurt, she had difficulty moving it and it intermittently lost feeling and then it would come back. She has been icing it and she knows it is supposed to be kind of sore, but states every so often her arm goes numb where she got the injection and asked if it was normal. Therapeutic measures were taken as a result of arm goes numb at injection site/it intermittently lost feeling. The patient did not recover from arm goes numb at injection site/it intermittently lost feeling, while the outcome of the other events was unknown.
Patient was supposed to receive the meningococcal conjugate vaccine today, but nurse accidently gave the Meningococcal B vaccine (erythema/swelling at injection site, fatigue for a couple days-nausea headache, and diarrhea can also occur).  The vaccine dose is valid, but we will not give the 2nd dose of the meningococcal B (Bexsero) series until patient is of an appropriate age ( 16-17 yo).  Spoke with patients mother and patient will receive meningococcal conjugate vaccine at his next visits. (12 yo WCC).     Patient had no reaction per mother  "arms are a little sore".
I was having seizure auras +/- a week after my booster shot that were very frequent.  I thought I was having panic attacks but the symptoms were actually auras.  I had a full seizure where I lost consciousness on February 4th, 2022 around noon.  I was at work when this happened and I was rushed to the hospital.
pt recvd vax 10OCT95;11OCT95 AM already showing signs of infect, high fever, arm swollen shoulder to elbow hosp & culture done;results not known @ prison & on IV
Narrative:  COVID POSITIVE FOLLOWING COMPLETING OF COVID VACCINE SERIES 01/13 COVID vaccine dose #1 02/04 COVID vaccine dose #2 02/22 pt tested for COVID as part of pre-procedure to start radiation therapy, tested positive, no symptoms 03/04 quarantine ended, remained asymptomatic 03/10 seen in ED due to fall (tangled feet in o2 tubing); tested positive for covid; admitted to r/o stroke 03/12 discharged from hospital 05/10 still testing COVID positive but no symptoms
Had second Shingrix dose July 11. Fatigue and headaches have persisted through July 17. CDC and other public information states symptoms only last 2-3 days. I'm reporting this because unless my reaction is rare, people should know that side effects can last longer than just 3 days. I had no reaction at all to the first dose. It's not a problem with Shingrix itself, I understand vaccine can have side effects. I believe the public information about the vaccine should include that side effects can persist more than 3 days and that the type of headache can require more than an otc nsaid. Here's what it took to knock down my latest headache: 3 consecutive cold packs, 3 Advil, one Excedrin migraine, and finally half a hydrocodone.
On day five in the evening I noted itching in upper right arm, however, ignored it.  Day six noted red circle about size of tennis bell, deepened redness. Day seven much heat at injection site, swelling deepened. Day eight Rash developed below swollen, red site, intense itching.  There was a considerable difference in temperature at the injection and the arm below the site. I am anemic and am usually pretty cool. Today is Monday 3/29/21, and as I have an appointment with my endocrinologist, I will ask her opinion. I only felt fatigued for about 3-4 days following initial injection.  I am feeling fairly normal at this time, but am wondering if this heat and swelling and redness, now spreading to a generalized rash on entire upper arm, is a normal event.
This spontaneous report as received from a registered nurse refers to a male patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose and lot number were not reported), subcutaneous. Concomitant medications were not reported. Registered nurse reported on behalf of a physician that on an unknown date, a patient who recently received the ZOSTAVAX, was also diagnosed with shingles shortly after receiving the vaccination. The outcome of shingles was reported as not recovered/not resolved. The relationship between the ZOSTAVAX and the events was not reported. Additional information has been requested.
fever started 7PM 23JUN97 gone in AM on 24JUN97 started again 24JUN97 5PM thru 25JUN97 high peaked kind of cry x 2noc had runny nose, phlem;